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Mitochondria form a complex, interconnected reticulum that is main-
tained through coordination among biogenesis, dynamic fission,
and fusion and mitophagy, which are initiated in response to various
cues to maintain energetic homeostasis. These cellular events, which
make up mitochondrial quality control, act with remarkable spatial
precision, but what governs such spatial specificity is poorly under-
stood. Herein, we demonstrate that specific isoforms of the cellular
bioenergetic sensor, 5′ AMP-activated protein kinase (AMPKα1/
α2/β2/γ1), are localized on the outer mitochondrial membrane, re-
ferred to as mitoAMPK, in various tissues in mice and humans. Activa-
tion of mitoAMPK varies across the reticulum in response to energetic
stress, and inhibition of mitoAMPK activity attenuates exercise-induced
mitophagy in skeletal muscle in vivo. Discovery of a mitochondrial
pool of AMPK and its local importance for mitochondrial quality
control underscores the complexity of sensing cellular energetics
in vivo that has implications for targeting mitochondrial energetics
for disease treatment.
mitochondria | AMPK | skeletal muscle | exercise | mitophagy
Mitochondria form a complex, interconnected reticulum (1–4)that is maintained through orchestrated remodeling pro-
cesses, such as biogenesis, dynamic fission and fusion, and tar-
geted degradation of damaged/dysfunctional mitochondria, called
mitophagy. These remodeling processes are collectively known as
mitochondrial quality control and are initiated by various cues to
maintain energetic homeostasis, which is particularly important
for tissues with high-energy demands (e.g., skeletal muscle and
heart) (5, 6). While the reticulum appears to respond to energetic
demand uniformly (1, 2, 7), mitochondrial quality control acts with
remarkable subcellular precision (8). For example, in both skeletal
muscle and heart, impaired or damaged regions of mitochondria
are separated from the functional reticulum in response to certain
cellular signals, setting the stage for their degradation by mitoph-
agy (1, 3, 9–13). However, what governs the spatial specificity of
this process is poorly understood.
The cellular energy sensor, 5′-AMP-activated protein kinase
(AMPK), is a heterotrimeric holoenzyme consisting of three subunits:
a catalytic α (α1 or α2), a scaffolding β (β1 or β2), and a regulatory
γ (γ1, γ2, or γ3) subunit (14). Canonically, AMPK senses cellular
energy status by monitoring AMP and/or ADP levels. AMP and/
or ADP bind to the γ subunit, resulting in a conformational change
that exposes the T172 site of the catalytic α subunit to phosphory-
lation at T172 (15–19), fully activating AMPK (20). Muscle-specific
knockout of both α subunit isoforms impairs exercises capacity and
mitochondrial oxidative capacity (21), clearly linking energy sens-
ing of AMPK to mitochondrial function as well as tissue function.
Indeed, AMPK activation promotes mitochondrial fission in vitro
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through its direct substrate mitochondrial fission factor (Mff)
(22). We and others have previously demonstrated that induction
of mitophagy in response to energetic stress (e.g., exercise, fasting,
etc.) is controlled by AMPK-dependent phosphorylation of Unc-
51 like autophagy activating kinase 1 (Ulk1) at S555 in skeletal
muscle (9, 23). In sum, AMPK integrates cell energetics to
modulate mitochondrial quality control so to maintain energetic
homeostasis.
To reconcile the subcellular specificity of mitochondrial quality







Fig. 1. Identification of enymatically active AMPK on OMM in vivo. (A) Whole-cell lysates (WC), postnuclear lysates (PNL), and the corresponding enriched
mitochondrial fractions of Percoll gradient isolation frommouse GA and Heart were probed for pan-AMPKαwith Vdac, Catalase, and α-tubulin as loading and
purity controls (n = 3). CS denotes mixed whole-tissue lysate comprised of mouse skeletal muscle, heart, and liver. (B) Immunofluorescence confocal mi-
croscopy of longitudinal sections of C57BL/6 mouse plantaris muscle probed by pan-AMPKα (red) and Cox4 (green) antibodies and DAPI for nuclear DNA
(blue). Representative image of n = 3. (Scale bar, 20 μm.) (C) Enriched mitochondrial and cytosolic fractions isolated via differential centrifugation frommouse
GA muscle and probed for each AMPK subunit isoform. n = 3. (D) Enriched mitochondrial fractions from frozen GA muscle of AMPKβ1/β2 knockout (KO) and
wild-type littermate mice (WT). n = 3 per group. (E) Enriched mitochondrial fractions from mouse GA were treated with/without trypsin and probed for
AMPKα1/α2/β2/γ1 (n = 2 per condition). An illustration of the physical association of AMPK with OMM is presented below. (F) Enriched mitochondrial fractions
from human skeletal muscle biopsies (n = 2) and left ventricle biopsies (n = 3) were probed for AMPKα1/α2/β2/γ1. (G) AMPK activity in WC, cytosolic (Cyto), and
enriched mitochondrial (Mito) factions with (+) and without (-) AMP (n = 3). All data presented as mean ± SEM. ***P < 0.001 by two-way ANOVA.
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increase ADP and AMP (24, 25), the known activators of AMPK
(26, 27), we hypothesized that a proportion and/or subtype of
AMPK is localized at mitochondria. This pool of AMPKmay serve
as a gauge of energetic cues, particularly when and where ATP
production through oxidative phosphorylation becomes limited.
Herein, we uncovered that a particular combination of subunits
of AMPK are localized to mitochondria in a variety of tissues,
including skeletal muscle and heart in both mice and humans,
which we term mitoAMPK. We show that mitoAMPK is local-
ized to the outer mitochondrial membrane (OMM) and is acti-
vated in response to various stimuli of mitochondrial energetic
stress. mitoAMPK activity and activation are spatially variable across
the mitochondrial reticulum. Finally, we present evidence that sug-
gests activation of mitoAMPK in skeletal muscle is required for
mitophagy in vivo. Discovery of a pool of AMPK on mitochondria







Fig. 2. mitoAMPK is activated by mitochondrial energetic stress with spatial specificity. (A) Single FDB muscle fibers from C57BL/6 mice transfected with
pmitoABKAR were cultured on phenol-red–free Matrigel coated glass plates, and FLIM/FRET efficiency (E%) was measured at rest and following 20 min of
electrical stimulation-induced contractions and illustrated as representative heat map images (Left) and histogram (Right). (B) Calculated mean E%. n = 18
fibers across four independent experiments. (C) Representative heat map image of C2C12 myoblasts transfected with pmitoABKAR and imaged via confocal
microscopy prior to 15 and 60 min following administration of 2.5 μM Oligomycin. (D) Data presented as normalized FRET ratio (FRET/cerulean). n = 21 cells
per timepoint across two independent experiments. (E) Enriched mitochondrial fractions from GA muscles of sedentary (Sed) or immediately after 90 min of
gradient treadmill running (Ex) in dnAMPKα2 and WT littermate mice were probed for p-AMPKα1/2 (T172) and pan-AMPKα. WT-sed (n = 13), WT-Ex (n = 13),
dnTG-Sed (n = 7), and dnTG-Ex (n = 8). (F) Quantitative data of phosphorylated AMPK relative to total AMPK and total AMPK relative to Vdac. (G) Enriched
mitochondrial fractions and corresponding cytosolic fractions from GA muscles of sedentary mice following 3 d metformin treatment (250 mg/kg via I.P.) or
saline were probed for p-AMPKα1/2 (T172) and pan-AMPKα. For both groups, n = 5. (H) Quantitative data of phosphorylated AMPK relative to total AMPK in
both Mito and Cyto fractions as well as total AMPK relative to Vdac. (I) Oxygen consumption rates of permeabilized TA muscle fibers in the presence of
glutamate (10 mM) and malate (1 mM) were added to determine complex I leak respiration in the presence of physiological free ADP levels (20 μM) followed
by titration of Metformin into the chamber (n = 3, run in triplicate). (J) Representative trace of complex I leak respiration during metformin titration. All data
are presented as mean ± SEM. Results of the paired Student’s t test (B), one-way ANOVA (D), two-way ANOVA (F), unpaired Student’s t test (H), and repeated
measures ANOVA (I) are *P < 0.05, **P < 0.01, and ***P < 0.001.
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complexity of energetic monitoring in vivo and could facilitate
development of strategies of targeting mitochondrial energetics
to treat diseases related to impaired mitochondrial function.
Results
Identification of Enymatically Active AMPK on OMM. To determine
whether AMPK is physically present in or associated with mi-
tochondria in vivo, we isolated mitochondria from adult mouse
gastrocnemius (GA) skeletal muscle and heart by Percoll gradient
centrifugation (SI Appendix, Fig. S1A), a gold standard method
of mitochondrial isolation for striated muscles (28), and per-
formed immunoblotting using anti-AMPK pan-α antibodies. We
readily detected AMPKα1/2 in these enriched mitochondrial
fractions (Fig. 1A). We also detected AMPKα1/2 in isolated mi-
tochondrial fractions via differential centrifugation from mouse
GA and tibialis anterior (TA) skeletal muscles, heart, and kidney
as well as liver (SI Appendix, Fig. S1B). Importantly, we con-
firmed that enriched mitochondrial fractions were free of cyto-
solic (evidenced via absence of α-Tubulin expression), endoplasmic
reticulum (ER) (evidenced via absence of Sec61a expression) (29),
or peroxisomes (evidenced via absence of Catalase expression)
(Fig. 1A and SI Appendix, Fig. S1 A and B), suggesting that our
detection of AMPK in enriched mitochondrial fractions was not
due to contamination from other organelles. Also, confocal im-
munofluorescence microscopy of longitudinal sections of mouse
plantaris skeletal muscle revealed a significant overlap of AMPK
signal with mitochondrial electron transport chain protein, cy-
tochrome oxidase 4 (Cox4) in the intermyofibrillar mitochondrial
network (Fig. 1B).
Given the heterotrimeric structure of AMPK holoenzyme and
the variation in possible subunit isoform composition across tis-
sues (14), we used isoform-specific AMPK antibodies for detec-
tion of AMPK isoforms in enriched mitochondrial fractions from
various tissues. We detected AMPKα1, α2, β2, and γ1 subunit
isoforms in mouse GA and TA muscles and heart as well as
differing variations of isoforms in kidney and liver (Fig. 1C and
SI Appendix, Fig. S1C). The identities of α1, α2, β2, and γ1 iso-
forms were confirmed in enriched mitochondrial fractions of
mouse GA by antigen peptide blocking, in which the primary an-
tibodies were preincubated by antigen peptides for the respective
antibodies (SI Appendix, Fig. S1D). We also performed cross
blocking and demonstrated that the antigen peptides we used
were specific for the designated antibodies (SI Appendix, Fig. S1E).
Importantly, we took advantage of GAmuscle of AMPKβ1/2 double-
knockout mice, which has previously been shown to have sig-
nificantly reduced expression of all AMPK subunits (30) and
observed a complete loss of AMPK α1, α2, β2, and γ1 isoforms in
enriched mitochondrial fractions isolated from frozen tissue
(Fig. 1D). Furthermore, using CRISPR/Cas9-mediated gene edit-
ing, we generated AMPKα2(T172A) knock-in mice and confirmed
loss of phosphorylation of AMPKα2 without a change of total
AMPK in enriched mitochondrial fractions (SI Appendix, Fig.
S1 E and F). Finally, to determine the precise location of AMPK
isoforms in mitochondria, we performed a gradual trypsin diges-
tion of isolated mitochondria from skeletal muscle and observed
disappearance of α1, α2, β2, and γ1 subunits along with the OMM
protein Tom20, while the inner mitochondrial membrane pro-
teins Cox4 and Cytochrome C remained intact (Fig. 1E). Most
importantly, we detected α1, α2, β2, and γ1 isoforms in enriched
mitochondrial fractions from human skeletal muscle and heart
(Fig. 1F), indicating that the physical association of AMPK with
mitochondria is conserved in humans.
AMPK activation is a three-step process with allosteric bind-
ing of AMP or ADP to the γ subunit promoting enhanced net
phosphorylation by upstream kinases and phosphatases of the cata-
lytic α subunit at residue T172 (15–19), leading to full activation (20).
We performed immunoprecipitated kinase assay (31) using enriched
mitochondrial fractions isolated via Percoll gradient centrifugation
and detected AMPK activity with clear evidence of allosteric
activation by AMP (Fig. 1G). Using antibodies against catalytic
α1 and α2 isoforms, we show the presence of AMPK activities for
both isoforms with α2 being more active than α1 across different
subcellular fractions (SI Appendix, Fig. S1H). The data presented
in SI Appendix, Fig. S1 E and F for the CRISPR/Cas9-generated
AMPKα2(T172A) knock-in mice are also consistent with the kinase
assay data. We also performed bioinformatic analysis by mining
three different protein–protein interaction (PPI) databases (32–34),
which revealed 62 mitochondria-associated proteins (35 native
mitochondrial proteins) that interact with AMPKα1 and 14 proteins
(two native mitochondrial proteins) that interact with AMPKα2
(SI Appendix, Fig. S1H and Tables S1 and S2). Taken together,
we present unequivocal evidence of physical association of en-
zymatically active AMPK of distinct isoforms with OMM, which
we term mitoAMPK.
mitoAMPK Is Activated by Mitochondrial Energetic Stress with Spatial
Specificity.Mitochondria present a reticular structure in most cells,
including the heart and skeletal muscle, in which the reticulum
extends across the entire length of myofibers (1, 2, 9, 10). To
visualize mitoAMPK activity in adult skeletal muscle, we per-
formed fluorescent lifetime Förster resonance energy transfer
microscopy (FLIM/FRET) in cultured myofibers from flexor dig-
itorum brevis (FDB) muscle transfected with the AMPK biosensor,
mitoABKAR (SI Appendix, Fig. S2A) (35). mitoABKAR consists
of an AMPK substrate sequence that is flanked by a cerulean
donor and a venus variant acceptor that is targeted to OMM via
a DAKAP1 targeting sequence (35). We digested and cultured
single FDB fibers at least 10 d after transfection and measured
FLIM/FRET energy transfer efficiency of the donor (E%) as an
indicator of mitoAMPK activity prior to and immediately following
20 min of electrical stimulation-induced contractions (Fig. 2A and
Movie S1). Muscle contractions resulted in increased mean E%
(Fig. 2B) in a heterogeneous pattern (Fig. 2A). We also mea-
sured mitoAMPK activation by transfecting C2C12 myoblasts,
which have endogenous mitoAMPK (SI Appendix, Fig. S2B), with
pmitoABKAR and treating them with oligomycin to inhibit ATP
synthase. As evidenced by an increase in acceptor fluorescence
when only the cerulean donor was excited (i.e., FRET signal) rel-
ative to the donor fluorescence, oligomycin treatment significantly
increased mitoAMPK activity with distinct regions of high FRET
along the reticulum (Fig. 2 C and D), further illustrating that
mitoAMPK is readily activated in a spatially distinct fashion as a
result of mitochondrial energetic stress.
To investigate whether mitoAMPK is activated in response to
energetic stress in vivo, we subjected C57BL/6J mice to various
mitochondrial energetic stressors. When we subjected the heart
and kidney to ischemia in mice via ligation of the left anterior
descending artery (LAD) and renal vessel clamping, respectively,
we obtained clear evidence of increased T172 phosphorylation in
enriched mitochondrial fractions (SI Appendix, Fig. S2 D–G).
Importantly, when we subjected mice to acute treadmill running
(90 min), we detected increased T172 phosphorylation in enriched
mitochondrial fractions from GA muscle immediately after ex-
ercise, but not in muscle-specific dominant-negative AMPKα2
transgenic littermate mice (dnTG) (Fig. 2 E and F). We also
observed increased AMPK T172 phosphorylation in both cyto-
solic and enriched mitochondrial fractions following repeated
contractions evoked by electrical stimulation compared to non-
stimulated contralateral control muscle (SI Appendix, Fig. S2C),
as well as 60 min of hindlimb ischemia by tourniquet application
(11, 36) compared with the contralateral TA muscle (SI Appendix,
Fig. S2 H and I). Finally, we tested the impact of administration of
metformin, an effective anti-diabetes drug that has shown to se-
lectively inhibit mitochondrial respiratory-chain complex 1 (37).
Daily intraperitoneal (i.p.) injection for 3 consecutive d resulted in
a significant increase in mitoAMPK T172 phosphorylation but not
4 of 10 | PNAS Drake et al.
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that of cytosolic AMPK (Fig. 2 G and H). In skinned skeletal
muscle fibers, in the presence of Glutamate/Malate and physio-
logical ADP (20 μM) (38), titration of Metformin impairs Complex
I-mediated respiration ex vivo (Fig. 2 I and J) but not respiration
capacity in muscle fibers from mice treated with metformin via i.p.
injections in the absence of metformin during the mitochondrial
respiration assay (SI Appendix, Fig. S2J). These findings suggest
that metformin-induced mitoAMPK activation is due to energetic
stress caused by direct inhibition of the mitochondrial respiratory
activity. Together, these findings provide strong evidence that
mitoAMPK can be activated by a variety of mitochondrial en-
ergetic stressors, which is consistent with a recent finding in mouse
liver that a mitochondrial pool of AMPK is activated in response
to extreme energetic stress (39). It is noteworthy that total mitoAMPK
did not show any significant changes under all conditions tested
(Fig. 2 E–H and SI Appendix, Fig. S2 C–I) except for dnTG with
elevated total AMPK in the mitochondrial fraction due to trans-
genic overexpression (Fig. 2 E and F). In sum, these data suggest
that mitoAMPK activation in vivo is not due to translocation of
AMPK to mitochondria, as has recently been suggested in cell
culture model systems (40).
mitoAMPK Activity Regulates Mitochondrial Quality Control. To in-
vestigate the functional role for mitoAMPK, we transfected C2C12
myoblasts with pmitoAIP (35), which encodes a targeted AMPK
inhibitor peptide (AIP) that consists of an AMPK-substrate se-
quence linked to an OMM targeting sequence and an mCherry
fluorophore for microscopic detection (SI Appendix, Fig. S3A).
Previous studies have shown that AIP acts as a kinase sink by
“out-competing” downstream substrates without disrupting na-
tive AMPK activation or affecting other potential AMPK pools
(35). We performed live-cell imaging via confocal microscopy
24 h posttransfection following staining with MitoTracker Deep
Red. Transfection with pmitoAIP led to significantly greater mito-
chondrial content compared with adjacent nontransfected cells or
cells transfected with the empty vector, pCIneo, or pmitoAIP(TA),
which has the AMPK-targeted threonine mutated to alanine
(Fig. 3 A and B). Increased mitochondrial content following in-
hibition of mitoAMPK activity is reminiscent of previous findings
by Egan et al. in primary hepatocytes in which ablation of either
AMPK or the mitophagy regulator Ulk1 led to accumulation of
mitochondria due to impaired mitophagy (41). However, trans-
fection of pmitoAIP or pmitoAIP(TA) did not prevent morpho-
logical changes related to mitochondrial fragmentation, induced
by treatment with oligomycin and antimycin A (SI Appendix, Fig.
S3 C and D) assessed by the MitoHacker imaging analysis platform
(42). The findings suggest that under the extreme condition of oli-
gomycin and antimycin (OA) treatment, inhibition of mitoAMPK
is not sufficient to mitigate mitochondrial fragmentation. How-
ever, these experimental findings do not exclude the possibility
that mitoAMPK may regulate mitochondrial dynamics, such as
mitochondrial fission, under physiological conditions.
We have previously shown that endurance exercise induces
mitophagy through AMPK-dependent phosphorylation of Unc-
51 like Ulk1 at Ser555 (9). To determine whether mitoAMPK is
required for mitophagy in vivo, we cotransfected mouse FDB muscle
via electroporation (SI Appendix, Fig. S3B) with pmitoAIP(-mCherry),
which is pmitoAIP with in-frame removal of the mCherry sequence
(SI Appendix, Fig. S3A), and pMitoTimer, a mitochondrial reporter
for visualizing mitochondrial oxidative stress and mitophagy (3, 9,
10, 43, 44). MitoTimer fluoresces like green fluorescence protein
(GFP; Ex/Em = 488/518 nm) when newly synthesized and irre-
versibly changes its fluorescence to that of Discosoma sp. red
fluorescent protein (DsRed; Ex/Em = 543/572 nm) when oxi-
dized (10). Cotransfection of the contralateral FDB with pCIneo
and pMitoTimer were used as control. pmitoAIP(-mCherry) trans-
fection resulted in a significant increase in theMitoTimer Red:Green
ratio compared to pCIneo transfection in the contralateral FDB
muscle (Fig. 3 C andD), indicating increased mitochondrial oxidative
stress. The data suggest that inhibition of mitoAMPK leads to
mitochondrial oxidative stress. We then subjected transfected mice
to 90 min of treadmill running and performed confocal microscopy
at 6 h post exercise, which corresponds to a peak of mitochondrial
oxidative stress and mitophagy (9). Treadmill running resulted in
a significant increase in MitoTimer Red:Green ratio in pCIneo-
transfected FDBmuscle compared with sedentary mice as previously
observed (9), whereas the contralateral pmitoAIP(-mCherry)–
transfected FDB muscle had a further increase from the elevated
Red:Green ratio following exercise (Fig. 3 C and D). pMitoTimer
pure red puncta are mitochondria containing autophagolysosomes
(positive for both mitochondrial protein Cox4 and lysosomal
marker Lamp1) (3, 9, 10). Here, we observed significantly in-
creased pure red puncta in pCIneo transfected FDB following
exercise, indicative of increased mitophagy (9) but not in the
contralateral FDB cotransfected with pmitoAIP(-mCherry) (Fig. 3 C
and D), suggesting an attenuation of exercise-induced mitophagy.
Therefore, activation of mitoAMPK may be required for mitophagy
BA
C D
Fig. 3. mitoAMPK activity regulates mitochondrial quality control. (A) Live
confocal imaging of C2C12 myoblasts transfected with pCIneo, pmitoAIP,
and pmitoAIP(TA) carrying mCherry (red) and stained with MitoTracker
Deep Red (gray) with nontransfected cells (NT) as control. (B) Quantification
of mitochondria occupied area as fold change relative to pCI-neo transfected
cells. pCIneo (n = 73), NT (n = 78), pmitoAIP (n = 29), and pmitoAIP(TA) (n =
30) between three independent experiments. (C) Representative images of
C57BL/6J mouse (10 to 12 wk) FDB fibers cotransfected with either pMito-
Timer and pCIneo or pMitoTimer and pmitoAIP(-mCherry). Images are
merged red and green channels. (Scale bar, 20 μm.) (D) Quantification of
MitoTimer Red:Green fluorescence intensity and pure red puncta. n = 10 per
group. Data presented as mean ± SEM. Results of one-way (B) or two-way
ANOVA (D) are *P < 0.05, **P < 0.01, and ***P < 0.001.
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induced by mitochondrial energetic stress, including endurance
exercise.
Discussion
From yeast to humans, AMPK has been credited with the control
of diverse responses and adaptations to energetic challenges to
maintain homeostasis. The notion that AMPK exists in distinct
subcellular domains has only relatively recently been given con-
sideration in the literature (45, 46), with the recent findings of
Zong et al. being the first to show a mitochondrial pool of AMPK
in vivo (39). Herein, we show that mitoAMPK in vivo consists of
distinct isoforms with variation between different tissues (Fig. 1C
and SI Appendix, Fig. S1C). We have obtained direct evidence that
α1, α2, β2, and γ1 isoforms are localized to the OMM in skeletal
muscle (Fig. 1E), and their association with mitochondria is at
least conserved in human skeletal muscle and heart (Fig. 1F).
We also show evidence for a localized activation of mitoAMPK
(Fig. 2) and in governing mitochondrial quality control in re-
sponse to energetic stress in skeletal muscle (Fig. 3), which may
be related to the highly spatial activation (Fig. 2A). Future studies
should elucidate the mechanism underlying mitoAMPK localiza-
tion and other local signaling pathways that may govern different
aspects of mitochondrial metabolism.
Recently, Zong et al. described a mitochondrial pool of AMPK
in mouse liver that was activated in response to severe nutrient
stress and ischemia (39); however, the specific isoforms that
comprised this mitochondrial pool of AMPK were not elucidated.
In the present study, we found physical presence of AMPK in
enriched mitochondrial fractions from multiple tissues (Fig. 1C
and SI Appendix, Fig. S1C). We confirmed in skeletal muscle that
AMPK α1, α2, β2, and γ1 isoforms are localized to the OMM
(Fig. 1E) and that their association with mitochondria is conserved
in human heart and skeletal muscle (Fig. 1G) as has been pro-
posed (47). We detected more mitoAMPK α2 activity in skeletal
muscle than that of α1 (SI Appendix, Fig. S1G), which is con-
sistent with the difference of expression levels in skeletal muscle
as previously reported (48). Whereas liver mitochondrial frac-
tions appeared to be more enriched for α2 over α1, and heart
and kidney appeared to be more biased toward α1 (SI Appendix,
Fig. S1C). Thus, it appears that a mitochondrial pool of AMPK
exists in most tissues, but the isoform composition of mitoAMPK
is tissue dependent. Our overall findings support the notion that
subcellular pools of AMPK may have unique functional roles
(39, 49).
The metabolic dissimilarity between tissues may relate to the
relative expression of mitoAMPK isoform composition. Com-
parison of ADP accumulation following brief periods of ischemia
across multiple tissues in rats demonstrates that heart and liver
accumulate ADP similarly, whereas the kidney is much more
sensitive to ischemia and accumulates twofold more ADP than
the heart and liver at the same time point (50). However, despite
similar accumulation in ADP between the heart and liver, only
AMPK phosphorylation in the liver increases in response to short
periods of ischemia, whereas AMPK phosphorylation in the heart
does not change (50). In the present study, ischemic periods were
optimized for each given tissue (60 min in skeletal muscle and
heart and as short as 5 min in kidney) to observe increased
mitoAMPK phosphorylation. Work in reconstituted systems has
shown that the isoform make-up of AMPK complexes determines
their sensitivity to energetic nucleotides (51). Therefore, our pre-
sent findings highlight an unappreciated complexity of AMPK
in vivo. Given that there are compounds that target specific
AMPK isoforms to modulate kinase activity (52, 53), our finding
of the mitochondrial-specific isoforms of mitoAMPK may pro-
vide an avenue for development of targeted therapeutics.
The presence of both α1 and α2 catalytic isoforms in enriched
mitochondrial fractions from myofibers may allude to isoform-
specific roles in modulating mitochondrial remodeling. AMPKα1
and α2 sequences are 84.4% similar in humans (83.5% in mice),
and the sequences on either side of the T172 activating site are
identical (20). However, the use of synthetic peptides in recon-
stituted systems has demonstrated differences in substrate specificity
between α1 and α2 (54), suggesting isoform-specific substrates. Our
rudimentary PPI analysis between AMPKα1 and α2 supports the
notion of distinct, though possibility related roles for the respective
isoforms. It will be important for future studies to elucidate these
possibilities as isoform-specific functions of AMPK may carry sig-
nificant implications for diseases associated with mitochondrial
dysfunction.
We demonstrated that various physiological energetic stressors
(e.g., repeated muscle contractions, ischemia, and treadmill running)
resulted in increased phosphorylation of T172 of mitoAMPKα.
Furthermore, a 3-d treatment with the widely prescribed anti-
diabetes drug metformin preferentially increased phosphoryla-
tion of T172 of mitoAMPKα in skeletal muscle along with evi-
dence of metformin-mediated inhibition of mitochondrial respiratory
complex I (Fig. 2 G–J), suggesting a role for mitoAMPK in
metformin’s action in skeletal muscle. While our physiological
data suggest that mitoAMPK responds to mitochondrial ener-
getic stress, recent studies have illuminated the spatial specificity
by which energetic stress is managed across the mitochondrial
reticulum in myofibers (1, 55). Using FLIM microscopy of an
OMM-targeted AMPK biosensor in cultured FDB myofibers, we
observed distinct areas of high FLIM E% (indicative of AMPK
activity) following 20 min of electrical stimulation-induced con-
tractions (Fig. 2A). This observation, when combined with a ∼10
to 12% variation in E% across the mitochondria in cultured
muscle fibers at baseline, illustrates a more nuanced response of
mitoAMPK to energetic stress, compared with the binary “on-
off” change observed by immunoblotting for T172 phosphoryla-
tion. It is known that AMP and/or ADP activates, whereas ATP
inhibits AMPK (26, 27, 56). Therefore, accumulation of AMP or
ADP at energetically stressed portions of the mitochondrial re-
ticulum may lead to localized activation of mitoAMPK, in line
with AMPK activation upon mitochondrial insults and low-energy
conditions (57). The observation of heterogenous activation of
mitoAMPK herein supports this notion.
Seminal studies by Egan et al. demonstrate that genetic de-
letion of AMPK or Ulk1 in cultured primary hepatocytes results
in an expansion of the mitochondrial reticulum, revealing the
importance of this signaling pathway in mitochondrial clearance
(41). We show here that competitive inhibition of mitoAMPK by
transfection of an OMM-targeted AMPK substrate peptide
(mitoAIP) but not the nonphosphorylatable peptide (mitoAIP(TA))
resulted in similar mitochondrial reticulum expansion in cultured
myoblasts, suggesting a pivotal role of mitoAMPK in control of
mitophagy. To reconcile the subcellular specificity of mitophagy
(8, 9) with the fact that exercise and other energetic stresses
increases ADP and AMP (24, 25), the known allosteric activator
of AMPK (26, 27), we hypothesized that spatial variability in
mitoAMPK activity and activation may implicate a role for
mitoAMPK in sensing local mitochondrial energetics to modu-
late mitochondrial quality control. mitoAMPK may then serve as
a gauge of mitochondrial energetic cues, particularly when and
where ATP production through oxidative phosphorylation becomes
limited. Using the established MitoTimer reporter gene for assess-
ing mitophagy in vivo (3, 9–11, 36), we demonstrate that inhibition
of mitoAMPK activity is sufficient to attenuate exercise-induced
mitophagy in skeletal muscle. Based on these data, taken in context
with spatial activation of AMPK across the reticulum in cultured
myofibers, we propose a working hypothesis that mitoAMPK acts
as an energetic surveillance mechanism to fine-tune mitochondrial
remodeling, such as mitophagy, for maintenance of energetic ho-
meostasis (Fig. 4). This notion is in line with the PPI model herein
and expands upon known functions of AMPK in mitophagy (9),
fission (22), and protein scaffolding (45). In the future, it will be
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important to discern how this local aspect of mitoAMPK in mi-
tochondrial quality control coordinates with other known localized
regulators of mitochondria, which may not be involved in the acute
exercise response (58, 59).
In conclusion, we have demonstrated that a mitochondrial
pool of AMPK is present in multiple tissues and consists of distinct
isoforms that are conserved between mice and humans. Our data
suggests that mitoAMPK is responsive to the energetic micro-
environment of the mitochondrial reticulum in a way that modulates
mitochondrial quality control mechanisms. Importantly, mitoAMPK
activation is involved in mitochondrial quality control at least through
the regulation of mitophagy. Collectively, these findings underscore
the complexity by which energetic monitoring occurs in vivo. Eluci-
dating the role of mitoAMPK in other pathways and how specific
pathologies may interfere with its function on the mitochondria will
be important areas of investigation going forward.
Materials and Methods
Animals. All animal procedures were approved by the University of Virginia
and Virginia Polytechnic Institute and State University Institutional Animal
Care and Use Committees. All mice were housed in temperature-controlled
(21 °C) quarters with 12:12-h light–dark cycle and ad libitum access to water
and chow (Purina). Wild-type mice (C57BL/6J, male, 8 to 12 wk old) were
obtained commercially (Jackson Laboratories) for mitochondrial isolation,
ischemia, exercise, electrical-stimulated muscle contraction, and somatic gene
transfer experiments. Male dnAMPKα2 mice and their wild-type littermates
(13 to 15 wk old) were from colonies bred in house (9). AMPKα2(T172A) knock-
in mice were generated using CRISPR/Cas9-mediated gene editing at Geneti-
cally Engineered Murine Model Core at University of Virginia as described (60).
The target sequence for the guide RNA (gRNA) is 5′-GAATTTCTACGAACTAGC-
TGG-3′, in which TGG is the protospacer adjacent motif (PAM) sequence and
ACT is the codon for threonine 172 that is mutated to GCT for alanine.
Cell Culture. For determination of the impact of inhibition of mitoAMPK on
mitochondrial fission, C2C12 myoblasts were cultured in 35-mm dishes and
transfected at 30 to 40% confluency with pmitoAIP (0.5 μg) or the control
plasmid pmitoAIP(TA) (0.5 μg) with Lipofectamine 2000 as described (61) for
24 h followed by treatment with oligomycin (10 μM) and antimycin (4 μM)
for 3 h and stained with MitoTracker (0.5 μM) for 30 min and with DAPI
(3.575 μM) for 10 min before fixation with 4% paraformaldehyde for
epifluorescence microscopy.
Bioinformatics. Mouse and human amino acid sequences for AMPKα1,
AMPKα2, AMPKβ1, AMPKβ2, AMPKγ1, AMPKγ2, AMPKγ3, and NDUFV2 were
obtained from UniProt (62). A hypothesis generating AMPKα1 and AMPKα2
mitochondrial interactome was created by compiling the results for mito-
chondrial proteins between three open-source PPI databases BioGrid3.5 (32),
GeneMania (33), and IntAct (34). Mitochondrial proteins were grouped
according to their biological function(s) based on gene ontology and
UniProt annotation.
Human Tissue Procurement. De-identified human muscle tissues were col-
lected from the discarded tissues after standard surgical procedures (e.g.,
knee or shoulder reconstruction). Tissues were collected from the Depart-
ment of Surgery at the University of Virginia School of Medicine. Institu-
tional Review Board (IRB) approval was not required since samples had been
de-identified. Human left ventricle biopsies were obtained at Stanford
University from nondiseased donor hearts rejected for orthotopic heart
transplantation and procured for research studies. Hearts were arrested in
cardioplegic solution and transported on ice following the same protocol as
hearts for transplant. The left ventricular free wall myocardium was dissected
from epicardial adipose on ice, rinsed in cold phosphate-buffered saline, and
rapidly snap-frozen in liquid nitrogen. Tissues were de-identified, and clin-
ical information was used to select nonischemic hearts with left ventricular
ejection fraction (LVEF) greater than 50%. Frozen tissues were transferred to
the University of Virginia through a material transfer agreement and IRB
approved protocols.
Mitochondrial Fraction Isolation. Mitochondrial-enriched lysates were iso-
lated via differential centrifugation (9), or Percoll gradient fractionation
from fresh GA and TA muscles, heart, liver, and kidney as described (63). For
Percoll gradient isolation, whole-tissue lysates in fractionation (FRAC) buffer
(20 mM Hepes, 250 mM Sucrose, 0.1 mM EDTA plus protease [Roche Diag-
nostics], and phosphatase [Sigma] inhibitors), were spun at 800 g for 10 min
at 4 °C, and the resulting supernatant, termed postnuclear lysate, was lay-
ered on top of a 20 to 60% Percoll gradient and spun at 36,000 × g at 4 °C
for 60 min. Mitochondrial layer was evident at the top of 20% Percoll layer,
which was isolated and diluted in FRAC buffer and spun at 17,000 × g at 4 °C
Fig. 4. A working model of the regulation and function of mitoAMPK in mitochondrial remodeling. Mitochondrial energetic stress under the conditions of
ischemia, muscle contraction, and/or pharmacological inhibition of mitochondrial respiratory chain will lead to subcellular increase of AMP and/or ADP in the
vicinity of damaged/dysfunctional mitochondria (indicated by mitochondria of red color), which binds to and activates mitoAMPK (increased phosphorylation
by upstream kinases). Activation of mitoAMPK promotes mitochondrial biogenesis, fission, and mitophagy through phosphorylating PGC-1a, MFF1, and
ULK1, respectively. Cooperation of PGC-1a and NRF1/2 action in the nuclear genome with TFAM action in the mitochondrial genome drives mitochondrial
biogenesis to add new, functional mitochondria (indicated by mitochondria of green color). Activated MFF1 interacts with DRP1 in executing mitochondrial
fission for the physical separation the damaged/dysfunctional portion of mitochondria from the mitochondrial reticulum. Activated ULK1 promotes for-
mation and targeting of autophagosome to damaged/dysfunctional mitochondria, which fuses with lysosome for degradation in autolysosome. This working
model points to the central role of mitoAMPK in sensing mitochondrial energetic stress and regulating mitochondrial remodeling with subcellular specificity.
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for 10 min. The pellet was resuspended in FRAC buffer and spun again until
a solid pellet formed at bottom of the tube, designated as mitochondrial
fraction (Mito). The whole-tissue lysates, postnuclear lysates, and mito-
chondrial fractions were each resuspended in Laemmli buffer containing
phosphatase (Sigma) and protease (Roche Diagnostics) inhibitors and boiled
for 5 min at 97 °C, then frozen at −80 °C until further analysis. For isolation
of mitochondria-enriched fraction from C2C12 myoblasts, cells were scraped
from plates in FRAC buffer containing protease (Roche Diagnostics) and
phosphatase inhibitors (Sigma) and lysed by passing through a 20-gauge
syringe at least 10 times. The mitochondria enriched fraction was isolated via
differential centrifugation (9).
Western Blotting.Western blotting was performed as described previously (9)
using the following primary antibodies: pan-AMPKα (CST no. 2532), p-AMPKα1/
2(T172) (CST no. 2535), AMPKα1 (Abcam no. 3759), AMPKα1 antigen (Abcam
no. 40461), AMPKα2 (Abcam no. 3760; NBP2-38532; NBP2-38532PEP), AMPKβ1
(CST no. 4178), AMPKβ2 (Novus Biologicals no. 92286), AMPKβ2 antigen (Novus
Biologicals no. 92286PEP), AMPKγ1 (Abcam no. 32508), AMPKγ1 antigen
(Abcam no. 218345), AMPKγ2 (Novus Biologicals no. 89324), AMPKγ2 antigen
(Novus Biologicals no. 89324PEP), AMPKγ3 (Abcam no. 38228), Vdac (CST no.
4661), Tom20 (CST no. 42406), Cox4 (CST no. 4859), Gapdh (CST no. 2118),
α-Tubulin (mouse, Abcam no. 7291), Catalase (rabbit, Abcam no. 16731), and
Sec61a (CST no. 14867). Proteins were analyzed in comparison to a common
protein standard loaded on the gel, which consisted of a whole-tissue lysate
mixture of liver, heart, and skeletal muscle.
Immunohistochemistry. Plantaris muscle was harvested, prepared, and used
for immunofluorescence as described (64) using anti-Cox4 (CST no. 2535) and
rabbit pan-AMPKα (Abcam no. 131512) with appropriate negative control.
Images were collected via confocal microscopy using Olympus Fluoview FV1000.
Antigen Blocking. Primary AMPKα1, AMPKα2, AMPKβ2, and AMPKγ1 anti-
bodies were preincubated with/without 5× or 10× (α2 only) molar concen-
tration respective antigen for 1 h at room temperature before used for
Western blotting.
Mitochondrial OMM Digestion. Mitochondria fractions were incubated in 0.5
or 1.0 μg/μL Trypsin (Thermo) in FRAC buffer on ice for 15 min (65) followed
by addition of 2 mM phenylmethylsulphonyl fluoride (Sigma) and incubation
on ice for another 5 min. The lysates were then spun at 11,000 × g for 10 min
at 4 °C, and the pellets were resuspended in Laemmli buffer plus protease
(Roche Diagnostics) and phosphatase (Sigma) inhibitors and boiled for 5 min
at 97 °C, then frozen at −80 °C until further analysis.
AMPK Kinase Assay.AMPK from cytosolic andmitochondrial fractions purified
via Percoll gradient isolation was immunoprecipitated using anti-AMPKα1
(Abcam no. 3759), anti-AMPKα2 (Abcam no. 3760), and anti–pan-AMPKα
(CST no. 2532) antibody and assayed as described previously (31).
Acute Treadmill Running Exercise. Acute treadmill running and prior accli-
matization was performed as previously described (9).
Hindlimb Ischemia. Acute hindlimb ischemia was performed as previously
described (11, 36).
Cardiac Ischemia. Cardiac ischemia was induced in vivo by ligation of the LAD
artery (66, 67).
Kidney Ischemia. Kidney ischemia was induced by unilateral clamping of renal
vessels (12975473). The nonischemic contralateral kidney was excised to serve
as control.
Electrical Stimulation. Stimulation of the TA muscle was performed as pre-
viously described (11, 68) at 100-Hz stimulation frequency, 300-ms stimula-
tion duration every second, 0.3-ms pulse duration, and 15-V electric
potential for 20 min. Stimulation of cultured, single FDB muscle fibers was
performed by insertion of a custom, three-dimensional (3D)–printed insert
containing two parallel platinum electrodes ∼10 mm apart into a Attofluor
cell chamber (Invitrogen) that was filled with Tyrode’s buffer (137 mM NaCl,
2.7 mM KCl, 1.8 mM CaCl22H2O, 1 mM MgCl26H2O, 0.2 mM NaH2PO4, 12 mM
NaHCO3, and 5.5 mM Glucose, pH = 6.5). The 3D-printed stimulation insert
has a rectangular opening in the center for microscope visualization. Stim-
ulation was modified from previous studies (69–71), which consisted of
70-Hz stimulation frequency, 350-ms stimulation duration every 2 s, 0.3-ms
pulse duration, and 150-V electric potential for 20 min.
Metformin Treatment. We performed daily intraperitoneal injection of
metformin at 250 mg/kg for 3 d (72). GAmuscles were harvested 1 h after the
last injection.
Mitochondrial Respiration. Mitochondrial respiration was assessed via oxygen
consumption rates of permeabilized muscle fibers measured through a high-
resolution respirometry device (O2k, Oroboros Instruments, Innsbruck,
Austria) and performed in triplicate. Methods for dissection, permeabiliza-
tion, and specific substrate-uncoupler-inhibitor titration (SUIT) protocol for
determining Complex I respiration were adapted from previously published
protocols (73, 74). Briefly, one TA muscle from each mouse was dissected
into fiber bundles ranges in size from 5 to 15 myofibers per bundle and
permeabilized with 100 μg/μL of saponin in Buffer ×. Fiber bundles were
then rinsed for 15 min in Buffer Z before being separated, and 2.5-mg
portions were loaded into respirometry chambers. Measurements were
performed in triplicates at 25 °C with constant stirring and oxygen concen-
tration maintained between 500 and 300 μM/L. Baseline respiration rate was
recorded after the fiber bundles were given time to equilibrate to the O2k
chamber and before the addition of any respiration substrates. For met-
formin titration experiment, glutamate (10 mM), malate (1 mM), and ADP
(20 μM) were added to determine complex I leak respiration in the presence
of physiological free ADP levels in mouse skeletal muscle (38). Metformin
was then titrated into the chamber at 0.025, 0.05, 0.1, 0.25, 0.5, and
1.0 mmol. Rates were allowed to stabilize for at least 4 min between additions.
For postmetformin treatment experiments, the following was performed:
First, glutamate (10 mM) and malate (1 mM) were added to determine
complex I leak respiration, followed by succinate (10 mM) to determine
combined complex I&II leak respiration. ADP (2.5 mM) was added at a sat-
urating concentration to determine max state III respiration followed by the
addition of rotenone (0.5 μM) to inhibit complex I. Complex I inhibition
allowed for the determination of complex I contribution to state III respi-
ration by calculating the percent decline of the state III respiration rate after
the addition of rotenone which results in the percent of Complex I contri-
bution to state III respiration. Cytochrome C (10 μM) was then added to
assess mitochondrial membrane integrity, and any test in which the rate
increased 10% after the addition of cytochrome C was excluded from analysis.
Lastly, uncoupled respiration (maximum capacity) was achieved by the addi-
tion of carbonyl cyanide p-trifluoromethoxyphenylhydrazone (FCCP) (0.15 μM).
Oxygen consumption rates were normalized to wet weight of tissue loaded
into the chamber. Initial baseline respiration rates were subtracted from all
rates before analysis.
Plasmid DNA and Transfection. Plasmid constructs were transfected into the
FDB muscle by somatic gene transfer as previously described (9–11, 75).
Culture of Single FDB Fibers. FDB muscles were removed intact and placed in
1 mL collagenase solution (0.2% Type-II collagenase and 0.2% bovine serum
albumin in Tyrode’s buffer with 1% PenStrep) in a 24-well culture plate.
Muscles were incubated for 2 h. at 37 °C in a tissue culture incubator and
agitated every 30 min. Muscles were then transferred to warmed 10% fetal
bovine serum (FBS) Dulbecco’s modified eagle medium (DMEM). Single
muscle fibers were dispersed by passing gently through wide-mouthed
plastic Pasteur pipette 30×. Aliquots of media containing single FDB fibers
were placed on glass slides coated with Phenol-Red Free Matrigel and in-
cubated at 37 °C in a tissue culture incubator for 30 min to adhere to the
Matrigel. Phenol-Red Free DMEM with 10% FBS was then added to each
slide for at least 30 min before any imaging was performed.
FLIM/FRET Imaging. FLIM/FRET is ideal for live-cell imaging, because the signal
is independent of biosensor concentration and change in fluorescent exci-
tation intensity but sensitive to changes in cellular environment, thus
allowing measurement of dynamic events at very high temporal (nanosec-
onds) and spatial resolution (76). FLIM of cultured single FDB fibers before
and after electrical stimulation was performed on a Zeiss 780 confocal/FLIM
laser scanning microscopy controlled with Zen software (Carl Zeiss, Inc).
Multiphoton excitation of the Cerulean donor of pmitoABKAR (35) was
achieved by using a Ti:sapphire laser (Ex: 820 nm), operating at 80 MHz
repetition rate (Chameleon Vision II, Coherent, Inc.). The fluorescence decay
per pixel was measured using Time-Correlated Single Photon Counting
(Becker & Hickl) in which single-photon counting module (SPCM) software
was used to acquire the FLIM data (version 8.91). E% was calculated in SPCM
software as E%2 = 1 – (τ1/τ2), with τ1 being the quenched donor lifetime
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and τ2 is the unquenched donor (77). Details of the FLIM set-up have been
discussed elsewhere (78). A Zeiss 40× 1.3 NA oil (Zeiss EC Plan-Neofluar,)
objective lens was used to focus the light on the sample and collect the
emission for 16 s. The average power at the specimen plane (7 mW) and the
acquisition time were chosen to reduce any photodamage to the cells. After
acquisition of FLIM images for Cerulean, the fluorescent lifetime images
were fitted for two components using SPCImage software (version 5.5,
Becker & Hickl). FLIM efficiency (E%), donor lifetime, and photon images for
each pixel was generated. For FRET imaging of C2C12 cells transfected with
pmitoABKAR, cells grown on glass plates were transferred to live-cell im-
aging chambers (Invitrogen) in phenol-red–free DMEM with 20% FBS. Im-
ages were acquired at with Leica HCX PL APO CS 63x 1.4NA Oil ultraviolet
(UV) lens at a resolution of 512 × 512 and 12 bits gray level and 1 airy unit on
a Leica SP5 × confocal microscope. Cerulean donor was excited at 457 nm,
and the FRET emission was captured at 475 to 503 nm. All images were
acquired using identical parameters to ensure no signal saturation and
similar intensity. Once the positively transfected cell had been identified and
baseline images acquired, media was removed and replaced with serum and
phenol-red free DMEM containing 2.5 μM Oligomycin. Subsequent images
were acquired at 15, 30, 45, and 60 min after media change. Normalized
FRET to Donor (Cerulean) ratio was calculated using the PFRET plugin in
Image J (79).
Confocal Microscopy. MitoTimer in adult muscle fibers was performed as
previously published (3, 9–11). For C2C12 cells transfected with pmitoAIP,
cells on glass plates were stained with 400 nM MitoTracker Deep Red in
DMSO (Sigma) for 30 min and transferred to live cell imaging chambers
(Invitrogen) in phenol-red–free DMEM with 20% FBS. Images were acquired
at 100× magnification (Olympus Fluoview FV1000) using red (via 543-nm
laser) and far red (via 635-nm laser) channels through a tetramethylrhod-
amine (TRITC) (Ex/Em 555/580 nm) and Alexa Fluor 647 filters (Ex/Em 649/666
nm), respectively. Mitochondrial content as a percentage of cell volume was
analyzed via mitochondria morphology macro in Image J (80).
Statistical Analyses. Data are presented as the mean ± SEM. Time course
experiments are analyzed via one-way ANOVA with Newman–Keuls post
hoc analysis. Where two variables are present, data were analyzed using
two-way ANOVA with Tukey post hoc analysis where appropriate. Where
one variable is present, data were analyzed using Student’s t test. Data with
significantly unequal variance was transformed prior to statistical analysis.
Statistical significance was established a priori as P < 0.05.
Data Availability. All study data are included in the article and/or supporting
information.
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